Tarceva
Sep 11, 2008 at 09:16 | Source: CNBC-TV18
Mar 19, 2008 at 14:56 | Source: CNBC-TV18
Mar 19, 2008 at 14:50 | Source: CNBC-TV18
Mar 11, 2008 at 09:28 | Source: CNBC-TV18
Jan 24, 2008 at 16:37 | Source: CNBC-TV18
Jan 11, 2008 at 10:16 | Source: Moneycontrol.com
News across the web »
Apr 13, 2012 at 22:00 | Source: Bloomberg
Dec 22, 2011 at 06:21 | Source: Reuters-India
Dec 22, 2011 at 04:41 | Source: Reuters
Dec 12, 2011 at 23:12 | Source: The Hindu BusinessLine
Related News »
5,747,498 (reissued as RE 41,065) and 6,900,221, which cover Tarceva (erlotinib) tablets and their use. The lawsuit was based on an Abbreviated New Drug Application (ANDA) filed by Mylan seeking permission from the FDA to manufacture and market a generic ...
May 15, 2012 at 14:28 | Source: comcast.net
Erbitux (cetuximab), Tarceva (erlotinib), Iressa (gefitinib) and Vectibix, are used to treat EGFR-expressing tumors. The cornea is covered with a layer of epithelium, which may become damaged when patients are receiving EGFR treatment.
May 22, 2012 at 21:01 | Source: Newsinferno.com
The "MARQUEE" trial compares tivantinib plus Takeda's Tarceva against Tarceva alone in previously treated non-small cell lung cancer patients. The study's primary endpoint is overall survival. Peyronie's is a buildup of scar tissue that causes extreme (and ...
May 22, 2012 at 16:50 | Source: Inside Fidelity
Sales forecast, targeted therapy , phase III, phase 3, pipeline, GVAX, HyperAcute Pancreas, Irinotecan, Sutent, GV1001, Afinitor, Avastin, AMG479, Abraxane, Masitinib, Gemzar, Nexavar, S-1, Tarceva, Certican, Novartis For more information visit
May 18, 2012 at 09:17 | Source: CNBC
The company's flagship product is Tarceva, a small molecule inhibitor of the epidermal growth factor receptor (EGFR) in the Oncology segment. The company's product pipeline include Erlotinib tablets, OSI-906, OSI-027, OSI-930 for oncology, PSN821 ...
May 12, 2012 at 08:12 | Source: Transworld News
"But if a patient needs a new targeted therapy like the lung-cancer drug Tarceva, he may end up paying a substantially higher percentage of the cost than he would have had there been a comparable intravenous drug." There is no oral oncology ...
May 15, 2012 at 06:14 | Source: USA Today
Erbitux® is a registered trademark of ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company. Tarceva® is a registered trademark of OSI Pharmaceuticals, LLC, an affiliate of Astellas Pharma US, Inc. Avastin® is a registered trademark ...
May 7, 2012 at 13:33 | Source: TMCnet
About three years ago, Cipla had taken on Swiss pharma giant Roche Holdings by launching a generic version of erlotinib at Rs46,000 for a month’s therapy, as against the price Rs140,000 charged by Roche for its branded drug Tarceva.
May 14, 2012 at 02:48 | Source: DAWN Group
And there was largely no competition due to patent protection. But in 2009, Cipla launched a copy of Roche’s Tarceva (erlotinib), challenging the foreign company’s patent on the drug and pricing its version at Rs46,000 for a month’s therapy.
May 8, 2012 at 18:04 | Source: Livemint.com
She battled bravely for 16 months, aided by an experimental drug called Tarceva, which has been found to help some female cancer patients in their post-menopause years. Her death last October happened to coincide with new recommendations issued ...
May 15, 2012 at 15:47 | Source: Hawk Eye